 |
July 28, 2003
Contact: Jim Sellers (503) 945-5738
Technical contact: Mel Kohn, M.D. (503) 731-4023
Methadone use, deaths reported increasing in Oregon
An Oregon Department of Human Services (DHS) review of methadone-related deaths
reveals a 4-fold increase since 1999. Of the 245 methadone-related deaths that
Oregon recorded between 1992 and 2002, 103 (nearly 45 percent) occurred in 2002.
"Although methadone is widely used without a problem, this recent increase
in deaths is concerning," said Mel Kohn, M.D., state epidemiologist in DHS.
"Patients who take methadone need to understand the special properties of this
medication so they can safeguard themselves. Health-care providers also should
take extra care to make sure their patients are well-informed about these aspects
of methadone."
Methadone is a long-acting synthetic opiate that the federal Food and Drug
Administration approved for medical use in 1947. It was approved for the treatment
of heroin addiction in 1972 and more recently has been used increasingly for
chronic pain.
The increase in methadone deaths in Oregon occurred among those who were using
it for heroin addiction and for chronic pain. The largest increase in deaths
was among those taking methadone for pain. Most of those who died had taken
other drugs in addition to methadone, according to Kohn.
"Methadone takes time to build to an effective level in the body and every
person metabolizes the drug differently," Kohn said. "A patient who seeks rapid
relief by adding other drugs could be making a deadly decision.
Taking extra doses is also dangerous, because methadone is broken down slowly
by the body. It can build up insidiously over time until it reaches a fatal
level."
Kohn said many of those who died were reported to be extremely drowsy, difficult
to awaken and loudly snoring. "Caregivers of people taking methadone need to
know that those signs could be an early warning sign of danger," he said.
The increase in deaths parallels an increase in methadone distribution. Between
1997 and 2001, methadone distribution in Oregon increased 5-fold; nationally
it increased 3.5-fold. Oregon now ranks fifth nationally in the amount of methadone
distributed per 100,000 persons.
The increase in methadone use nationwide may be due to its low cost and a lack
of alternative medications with similar properties, particularly for pain control,
according to Kohn. "Oregon's use of methadone may be particularly high because
of our strong focus on pain management," he said.
The review suggests that health systems may want to address the problem through
strategies such as automatic reminders to pharmacists and providers about the
danger of dispensing another drug when methadone is prescribed. "We don't know
the effect of such systematic approaches, but a careful evaluation of their
impact could help guide future policy change," Kohn said.
The review is the topic of
the new CD Summary, a bi-weekly newsletter sent to Oregon physicians and other
health professionals.
|
|